维罗纳制药第二季度每股收益0.13美元超出预期0.04美元，销售额1.03138亿美元超出预期9214万美元

Verona Pharma (NASDAQ: VRNA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.04 by 209.52 percent. This is a 116.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $103.138 million which beat the analyst consensus estimate of $92.140 million by 11.94 percent.